Show simple item record

dc.contributor.authorShepherd, Mairien
dc.contributor.authorLi, Juanen
dc.contributor.authorWilson, Nicolaen
dc.contributor.authorOedekoven, Carolineen
dc.contributor.authorLi, Jiangbingen
dc.contributor.authorBelmonte, Miriamen
dc.contributor.authorFink, Juergenen
dc.contributor.authorPrick, Janine CMen
dc.contributor.authorPask, Dean Cen
dc.contributor.authorHamilton, Tina Len
dc.contributor.authorLoeffler, Dirken
dc.contributor.authorRao, Anjanaen
dc.contributor.authorSchröder, Timmen
dc.contributor.authorGottgens, Bertholden
dc.contributor.authorGreen, Tonyen
dc.contributor.authorKent, Daviden
dc.date.accessioned2018-11-01T14:01:40Z
dc.date.available2018-11-01T14:01:40Z
dc.date.issued2018-08en
dc.identifier.issn0006-4971
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/284470
dc.description.abstractRecent advances in single cell technologies have permitted the investigation of heterogeneous cell populations at previously unattainable resolution. Here we apply such approaches to resolve the molecular mechanisms driving disease in mouse hematopoietic stem cells (HSCs), using JAK2V617F mutant myeloproliferative neoplasms (MPNs) as a model. Single cell gene expression and functional assays identified a subset of JAK2V617F mutant HSCs that display defective self-renewal. This defect is rescued at the single HSC level by crossing JAK2V617F mice with mice lacking TET2, the most commonly co-mutated gene in MPN patients. Single cell gene expression profiling of JAK2V617F-mutant HSCs revealed a loss of specific regulator genes, some of which were restored to normal levels in single TET2/JAK2 mutant HSCs. Of these, Bmi1 and, to a lesser extent, Pbx1 and Meis1, overexpression in JAK2-mutant HSCs could drive a disease phenotype and retain durable stem cell self-renewal in functional assays. Together, these single cell approaches refine the molecules involved in clonal expansion of MPNs and have broad implications for deconstructing the molecular network of normal and malignant stem cells.
dc.description.sponsorshipMS is the recipient of a BBSRC Industrial CASE PhD Studentship, and CAO and JF are recipients of Wellcome Trust PhD Studentships. Work in the Kent lab is supported by a Bloodwise Bennett Fellowship (15008), a European Hematology Association Non-Clinical Advanced Research Fellowship, and an ERC Starting Grant (ERC-2016-STG–715371). Work in the Green Lab is supported by the Wellcome Trust, Bloodwise, Cancer Research UK, the Kay Kendall Leukaemia Fund, and the Leukemia and Lymphoma Society of America. Dr. Kent, Professor Göttgens, and Professor Green are all supported by a core support grant from the Wellcome Trust and MRC to the Wellcome Trust – Medical Research Council Cambridge Stem Cell Institute the National Institute for Health Research Cambridge Biomedical Research Centre, the Cambridge Experimental Cancer Medicine Centre.
dc.format.mediumPrint-Electronicen
dc.languageengen
dc.publisherAmerican Society of Hematology
dc.subjectHematopoietic Stem Cellsen
dc.subjectAnimalsen
dc.subjectMice, Transgenicen
dc.subjectMiceen
dc.subjectHematologic Neoplasmsen
dc.subjectMyeloproliferative Disordersen
dc.subjectNeoplasm Proteinsen
dc.subjectAmino Acid Substitutionen
dc.subjectGene Expression Regulation, Neoplasticen
dc.subjectMutation, Missenseen
dc.subjectJanus Kinase 2en
dc.subjectNeoplastic Stem Cellsen
dc.subjectCell Self Renewalen
dc.titleSingle-cell approaches identify the molecular network driving malignant hematopoietic stem cell self-renewal.en
dc.typeArticle
prism.endingPage803
prism.issueIdentifier8en
prism.publicationDate2018en
prism.publicationNameBlooden
prism.startingPage791
prism.volume132en
dc.identifier.doi10.17863/CAM.31846
dcterms.dateAccepted2018-07-03en
rioxxterms.versionofrecord10.1182/blood-2017-12-821066en
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserveden
rioxxterms.licenseref.startdate2018-08en
dc.contributor.orcidShepherd, Mairi [0000-0002-4328-9882]
dc.contributor.orcidWilson, Nicola [0000-0003-0865-7333]
dc.contributor.orcidOedekoven, Caroline [0000-0002-2309-2097]
dc.contributor.orcidLoeffler, Dirk [0000-0001-9870-0088]
dc.contributor.orcidSchröder, Timm [0000-0001-9320-0252]
dc.contributor.orcidGöttgens, Berthold [0000-0001-6302-5705]
dc.contributor.orcidGreen, Anthony [0000-0002-9795-0218]
dc.contributor.orcidKent, David [0000-0001-7871-8811]
dc.identifier.eissn1528-0020
rioxxterms.typeJournal Article/Reviewen
pubs.funder-project-idLeukaemia & Lymphoma Research (12029)
pubs.funder-project-idCancer Research UK (21762)
pubs.funder-project-idWellcome Trust (097922/B/11/Z)
pubs.funder-project-idMRC (MC_PC_12009)
pubs.funder-project-idMEDICAL RESEARCH COUNCIL (MR/M008975/1)
pubs.funder-project-idMRC (MR/S036113/1)
rioxxterms.freetoread.startdate2019-08-23


Files in this item

Thumbnail
Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record